RAP raptor resources limited
Add to My Watchlist 0.00% ! 20.5¢

Ann: Medgate commences European ResAppDx trial, page-3

Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
  1. Bloky
    2,050 Posts.
    lightbulb Created with Sketch. 1660
    clock Created with Sketch.
    04/03/21
    09:19
    Post #: 51504215
    Dr Andy Fischer, CEO Medgate said: "We are absolutely convinced that the use of new technologies like ResAppDx will enable an advancement of our Digital Health platform. This will benefit our patients by enabling them to be treated conclusively by phone or video in even more cases
    RAP Price at posting: 5.9¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 44  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

NEWS The Japan Organization for Metals and Energy Security joins the Speewah fluorite project
right-arrow Created with Sketch.
NEWS Peregrine Gold discovers high grade channel iron deposit at Newman gold project, WA
right-arrow Created with Sketch.
NEWS World’s largest pollucite-hosted caesium pegmatite resource defined
right-arrow Created with Sketch.
NEWS Access the latest ASX news here
right-arrow Created with Sketch.
NEWS AnteoTech and Black Diamond Structures to Progress Advanced Battery Product in the USA
right-arrow Created with Sketch.
NEWS Nyrada completes final dosing in Xolatryp Phase I clinical trial
right-arrow Created with Sketch.
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.